(Q44114280)

29 November 2017

title

AT-1015, a newly synthesized 5-HT2 receptor antagonist, dissociates slowly from the 5-HT2 receptor sites in rabbit cerebral cortex membrane (English)

1 reference

29 November 2017

Mamunur Rashid

1

1 reference

29 November 2017

Masatomo Watanabe

series ordinal

2

1 reference

29 November 2017

Mikio Nakazawa

series ordinal

3

1 reference

29 November 2017

Takafumi Nagatomo

series ordinal

4

1 reference

29 November 2017

publication date

1 August 2002

1 reference

Journal of Pharmacy and Pharmacology

29 November 2017

published in

1 reference

29 November 2017

volume

54

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

1123-1128

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Bopindolol is a slowly dissociating beta 1-adrenoceptor antagonist when compared to other beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Antithrombotic activity of AT-1015, a potent 5-HT(2A) receptor antagonist, in rat arterial thrombosis model and its effect on bleeding time

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Effects of ketanserin and 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monohydrochloride (SGB-1534), anti-hypertensive agents, on 3H-serotonin and 3H-ketanserin bindings to serotonergic (5HT1 and 5HT2) receptors in dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Assessment of affinity and dissociation ability of a newly synthesized 5-HT2 antagonist, AT-1015: comparison with other 5-HT2 antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Binding affinity of a newly synthesized 5-HT2 antagonist, AT-1015 (N-[2-[4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-piperidino]ethyl]-1-formyl-4-piperidinecarboxamide monohydrochloride monohydrate), in the rabbit platelet membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Characterization of two [3H]ketanserin recognition sites in rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Inhibitory effects of a newly synthesized 5-HT2 receptor antagonist, AT-1015 (N-[2-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidino]-ethyl]-1-for myl-4-piperidinecarboxamide monohydrochloride monohydrate), on contraction and relaxation of pig cor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

AT-1015, a novel serotonin (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2A receptors and prevents the laurate-induced peripheral vascular lesion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

Candesartan (CV-11974) dissociates slowly from the angiotensin AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702320266299

10.1211/002235702320266299

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference